With lots of money at play, it’s not hard to see why the government is motivated to investigate and prosecute in order to obtain huge fines and the benefit of the forfeiture millions of dollars.
Tag: federal
OIG Releases Special Fraud Alert on Telemedicine Arrangements
With lots of money at play, it’s not hard to see why the government is motivated to investigate and prosecute in order to obtain huge fines and the benefit of the forfeiture millions of dollars.
Yet Another Physician Guilty of Receiving Insys/Subsys Kickbacks
In general terms, the federal Anti-Kickback Statute (“AKS”) prohibits the offer, demand, payment, and acceptance of remuneration—that is, of anything of value—for referrals.
Compound King Breaks Bad, Gets Creamed
Explore the shocking story of compound cream fraud involving pharmacist George Tompkins and a massive illegal billing scheme.
Compound King Breaks Bad, Gets Creamed – Success in Motion
Take a ride with Mark as he discusses the latest compound medicine kickback scheme to result in prison time.
Former Drug Company CEO Pleads Guilty and Will Cooperate in Upcoming Kickback Scam Prosecution
Former CEO Michael Babich pleaded guilty last week to charges related to the plethora of kickback allegations surrounding Insys Therapeutics, Inc., and its fentanyl drug, Subsys.
U.S. Government Intervenes in 5 Kickback Based Whistleblower Cases Against Insys – Success in Motion
Ride along while Mark discusses the expanding case involving Insys Therapeutics and kickbacks paid to induce prescription of its drug, Subsys.
Drugs, Sentencing and Lock (and Roll) on to Another Kickback Prosecution – Podcast
The federal Anti-Kickback statute makes it illegal to receive anything of value for the referral of federal health care program patients. How are you managing this potential pitfall?
Another Physician Guilty of Receiving Insys/Subsys Kickbacks
A physician is convicted in the Insys/Subsys kickback case, highlighting ongoing risks around pharma deals and compliance for medical group leaders.
Washington State Takes Antitrust Aim at Aggressive Health System Competition
Washington State targets anti-competitive behavior, signaling a broader shift in antitrust enforcement across the healthcare landscape.